General Information
BounceWatch is an independent company data service, not affiliated with Inceptor Bio. To contact Inceptor Bio, visit inceptor.bio.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Inceptor Bio compare?
A PDF of Inceptor Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Inceptor Bio soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United States Market
Biotechnology
About Inceptor Bio
Business keywords: cell therapy, gene therapy, cancer treatment, immunotherapy, tumor microenvironment, oncology, cancer research, immune cell performance, novel mechanisms, next-generation therapies
Funding Rounds & Investors (5)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Debt Financing | $15.88M | - |
|
20 Oct 2022 |
| Series A | $37.00M | 1 |
Kineticos Ventures
|
19 May 2022 |
| Debt Financing | $5.52M | - |
|
07 Jul 2021 |
| Seed Round | $26.00M | 1 |
Kineticos Disruptor Fund
|
14 Jun 2021 |
| Seed Round | $3.25M | - |
|
30 Sep 2020 |
Inceptor Bio Alternatives & Competitors
View All AlternativesPioneering optimally engineered NK cell therapies to cure patients with cancer.
3T is an immunotherapy company developing next-generation, transformative therapies for broad patien...
It’s about time we think smarter and faster than cancer.
FAQ About Inceptor Bio
Source: BounceWatch company record for Inceptor Bio, https://bouncewatch.com/company/inceptor-bio, updated 30 December 2024. When citing, please name BounceWatch and link this page.